| Symbol | IPIX |
|---|---|
| Name | INNOVATION PHARMACEUTICALS INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 01880 United States MA 301 Edgewater Place - Suite 100 |
| Telephone | (978) 921-4125 |
| Fax | — |
| — | |
| Website | http://www.ipharminc.com |
| Incorporation | US |
| Incorporated On | 2005 |
| Employees | — |
| Fiscal Year | 6/30 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | GreenGrowth CPAs; |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001355250 |
| Description | An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers. Additional info from OTC: |
Expert Market symbol attribute type Security_Name was changed. Previous value: -. New value: INNOVATION PHARMACEUTICAL.
Read moreOTCQX U.S. Premier symbol attribute type Security_Name was changed. Previous value: CONSUMERS BANCORP INC. New value: INNOVATION PHARMACEUTICAL.
Read more